Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × cediranib × Clear all

NCT00278343 2018-08-29

Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer

Phase 2 Completed

74 enrolled 11 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00275028 2015-11-09

AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

47 enrolled 15 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms